	Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: PostÂ Hoc Analysis of a Randomized Trial. Neurol Ther Antonini A, Bergmans B, Kern DS, Gandor F, Nishikawa N, Standaert DG, Fritz B, Gupta R, Nozaki T, Shah MB, Bergmann L, Kimber T. PMID: 41324738 [PubMed - as supplied by publisher]
	Deciphering Ferroptosis-Related Astrocyte Subpopulations and Diagnostic Biomarkers in Parkinson's Disease through RNA Transcriptomics. Mol Neurobiol Gong Z, Guo D, Lin Y, Liu Z, Lv M, Liu X, Sun M, Wang L, Zhao T, Wang Z, Xue X. PMID: 41324729 [PubMed - indexed for MEDLINE]
	Effects of glucocerebrosidase gene variations on the risk of Parkinson's disease dementia: a meta-analysis. Front Aging Neurosci Li Q, Bi Z, Liang W, Yin S, Li H, Liang Z, Wu M, Quan J, Li C. PMID: 41323658 [PubMed]
	New gait performance indices and cognitive functions: a pilot study on correlation in people with Parkinson's disease. Front Hum Neurosci Cocco ES, Thouant CL, Pietrosanti L, Infarinato F, Manzia CM, Romano P, Torcisi RSM, Franceschini M, Verrelli CM, Pournajaf S. PMID: 41323342 [PubMed]
	Anterior attentional system efficacy in Parkinson's disease: a cross-sectional study in Poland. Front Hum Neurosci Goli, Sawicki A, Bieleninik , Schinwelski M, Bidzan M. PMID: 41323340 [PubMed]
	Diagnostic Value of Carotid Intima-Media Thickness Combined with Periventricular White Matter Hyperintensities for Mild Cognitive Impairment in Parkinson's Disease. Neuropsychiatr Dis Treat Li S, Che F, Zhang Z. PMID: 41322659 [PubMed]
	Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects. Nanoscale Wafik Nabih N, Nafie MS, Babker A, Alameen AAM, Fahmy SA. PMID: 41321255 [PubMed - as supplied by publisher]
	Beyond Parkinson's Disease: A Narrative Review of Neuromelanin MRI in Neurodegenerative Diseases. J Neuroimaging Burade A, Lakhani DA, Dagher R, Anosh J, Sair HI, Luna LP. PMID: 41320758 [PubMed - indexed for MEDLINE]
	A scoping review of safer mobility behaviour assessment and intervention: implications for people with Parkinson's disease. Disabil Rehabil Cheung D, Wesson J, Paul SS, Mackenzie L, Goh L, Canning CG, Almeida LRS, Enright M, Allen NE. PMID: 41320561 [PubMed - as supplied by publisher]
	Telerehabilitation for people with Parkinson's disease: protocol of a randomised clinical trial of mixed methods. BMJ Open Taveira RS, Vasconcellos LS, Bezerra CF, Aires DN, Dias de Oliveira AK, da Silva KOC, Melo LP, Ribeiro TS. PMID: 41320221 [PubMed - indexed for MEDLINE]
	CCNE1 Exerts a Protective Effect on Parkinson's Disease by Regulating Ferroptosis-Related Proteins. Brain Behav Fu J, Zhao J, Mi N, Zhang C, Zhang Y, Yao L. PMID: 41319014 [PubMed - indexed for MEDLINE]
	Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review. Eur J Neurosci Bhamare UU, Talpade A, Pingili RB, Palkar MB. PMID: 41318966 [PubMed - indexed for MEDLINE]
	Mapping the neural and molecular basis underlying fatigue in Parkinson's disease. NPJ Parkinsons Dis Yang F, Shen J, Sun Z, Tan L, Yang R, Zhu L, Mo Y, Shao H, Hou J, Sun Z, Gao Y, Hou Y, Wang J. PMID: 41318614 [PubMed - as supplied by publisher]
	Advances in Neurological Therapies: A Review of Clinical Trials in Alzheimer's, Parkinson's, and Multiple Sclerosis. Am J Med de Souza PC, Bezerra TPW, de Melo Rêgo MJB, da Rosa MM. PMID: 41318018 [PubMed - as supplied by publisher]
	Effects of oral levodopa on motor symptoms and gait impairments in Parkinson's disease: a systematic review and meta-analysis. Expert Rev Neurother Lillebæk BS, Tran J, Dalgas U, Langeskov-Christensen M. PMID: 41317111 [PubMed - as supplied by publisher]
	Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta-Analysis. Mov Disord Marinescu AM, Machado V, Pagano G, Muelhardt NM, Kustermann T, Mracsko EZ, Brockmann K, Shariati N, Anzures-Cabrera J, Zinnhardt B. PMID: 41317029 [PubMed - as supplied by publisher]
	Bipolar Disorder as a Long-Term Risk Factor for Parkinson's Disease: A Nationwide Case-Control Study. Mov Disord Jaakkola E, Koponen M, Kaasinen V, Hietala J, Hartikainen S, Tolppanen AM. PMID: 41317018 [PubMed - as supplied by publisher]
	Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). Mov Disord Rascol O, Ory-Magne F, Meissner WG, Maltête D, Defebvre L, Azulay JP, Thobois S, Houeto JL, Thalamas C, Sommet A, Geny C, Damier P, Anheim M, Marquès A, Viallet F, Giroud M, Lefaucheur R, Costentin G, Spampinato U, Samier-Foubert A, Carrière N, Mutez E, Mariani LL, Eusebio A, Prange S, Benatru I, Charif M, Brefel-Courbon C, Fabbri M, Galitzky M, Rousseau V, Saubion A, Catala H, Ferreira JJ, Burn DJ, Corvol JC, PREMANDYSK Study Group. PMID: 41316871 [PubMed - as supplied by publisher]
	Dermal Alpha-Synuclein Aggregation in Seed Amplification Assays for Parkinson's Disease Subtype Differentiation. Eur J Neurol Vieregge M, Kuzkina A, Janzen A, Oertel WH, Sommerauer M, Volkmann J, Doppler K. PMID: 41316710 [PubMed - indexed for MEDLINE]
	Multi-Session whole body vibration program on Parkinson's disease symptoms: Systematic review and meta-analysis. J Bodyw Mov Ther González-García P, Heredia-Rizo AM, Garrido-Bueno A, Casuso-Holgado MJ, García-Bernal MI. PMID: 41316661 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 55661

Page 1 of 2784



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy